Spinal – CMF SpinaLogic

Key Features

  • Portable, battery powered non-invasive bone growth stimulator
  • Adjunct to lumbar fusion surgery
  • Works with both anterior and posterior approaches
  • Improves fusion rate by 49%
  • Padded with contoured cushioning ensures patient comfort
  • HCPCS E0748


Spinal – CMF SpinaLogic

A portable, battery-powered, micro-controlled, noninvasive bone growth stimulator indicated as an adjunct electromagnetic treatment to primary lumbar spinal fusion surgery for one or two levels.


Padded Comfort
Padded belting increases patient comfort, is easy to secure; trim to accommodate a wide range of sizes.

Anatomical Cushioning
Integrated, contoured cushioning ensures comfort where the coil rests against the body/spine.

Contoured Fit
Moldable belt allows close fit; easily contours to the patient’s body.

High Quality Materials
Soft, breathable, medical-grade fabrics are improved; distinctive two-tone coloring.

Typical Indications

Adjunct electromagnetic treatment to primary lumbar spinal fusion surgery for one or two levels.

  • "CMF, the only bone stimulating technology with an FDA approved mechanism of action, up-regulates synergistic growth factor signals, specifically, intracellular calcium, calmodulin & IGF II - all key factors in the formation of bone." - Washinton State Health Technology Assessment of Bone Growth Stimulators, 2009).
  • A multi-center, randomized, double blind study of 201 patients undergoing posterolateral lumbar spinal fusion without instrumentation reported a 64% success rate with CMF stimulation, versus 43% without (Linovitz et al., Spine 27:1383-9).
  • Patients with Charcot foot neuroarthropathy who received CMF treatment were able to resume ambulation in less than half the time of controls (11.1 weeks versus 23.8), and often with less joint destruction and residual deformity (J Foot Ankle Surg.1998;37(6):510-5).
  • Sales of bone stimulators, particularly the noninvasive spinal fusion stimulators, are climbing rapidly (Frost and Sullivan Research Report on “U.S. Bone Growth and Spinal Fusion Stimulators Markets”).
  • A 2008 survey of orthopedic surgeons regarding treatment of complicated tibial fractures, found that almost half (45%) of those responding employed bone stimulators as part of their management strategy (ActaOrthop.2008;79(5):689-94).


Would you like to talk about a product? Please contact us at 866.712.0881